ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Corporate Action, IR, Listing Regulation, News, Other, Regulatory, Swedish
November 18, 2024
21 Dec 2022

Garantikonsortiet utökas till att omfatta cirka 62 procent av Acarix pågående företrädesemission

DETTA PRESSMEDDELANDE ÄR EJ FÖR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING, VARKEN DIREKT ELLER INDIREKT, INOM ELL...
Continue reading
author-avatar acarix
Corporate Action, English, IR, Listing Regulation, News, Prospectus, Regulatory
November 18, 2024
14 Dec 2022

Acarix publishes prospectus in connection with the company’s rights issue

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAP...
Continue reading
author-avatar acarix
Corporate Action, IR, Listing Regulation, News, Prospectus, Regulatory, Swedish
November 18, 2024
14 Dec 2022

Acarix offentliggör prospekt i samband med bolagets företrädesemission

DETTA PRESSMEDDELANDE ÄR EJ FÖR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING, VARKEN DIREKT ELLER INDIREKT, INOM ELL...
Continue reading
author-avatar acarix
Corporate Information, English, General meeting, IR, Listing Regulation, News, Regulatory, Report of the AGM
November 18, 2024
09 Dec 2022

Announcement from Acarix’s extra general meeting

The extra general meeting of Acarix AB ("Acarix" or the "Company") was held today on 9 December 2022 and the following resolutions were...
Continue reading
author-avatar acarix
Corporate Information, General meeting, IR, Listing Regulation, News, Regulatory, Report of the AGM, Swedish
November 18, 2024
09 Dec 2022

Kommuniké från extra bolagsstämma i Acarix

Extra bolagsstämma i Acarix AB ("Acarix" eller "Bolaget") hölls idag den 9 december 2022 varvid aktieägarna fattade f&ou...
Continue reading
author-avatar acarix
Corporate Information, English, IR, Listing Regulation, News, Other Corporate Information, Regulatory
November 18, 2024
22 Nov 2022

Notice of Extra General Meeting in Acarix AB

The shareholders of Acarix AB, reg. no. 559009-0667, (the "Company"), are hereby convened to the extra general meeting to be held on Fr...
Continue reading
author-avatar acarix
Corporate Information, IR, Listing Regulation, News, Other Corporate Information, Regulatory, Swedish
November 18, 2024
22 Nov 2022

Kallelse till extra bolagsstämma i Acarix AB

Aktieägarna i Acarix AB, org. nr 559009-0667, ("Bolaget") kallas härmed till extra bolagsstämma fredagen den 9 december ...
Continue reading
author-avatar acarix
English, Interim, IR, Listing Regulation, News, Q2, Regulatory, Report
November 18, 2024
25 Aug 2022

Acarix AB (publ) publishes Interim Report, January – June 2022

Significant interest and positive developments in the US marketWe can now conclude that our Go-To-Market strategy in the USA has starte...
Continue reading
author-avatar acarix
Interim, IR, Listing Regulation, News, Q2, Regulatory, Report, Swedish
November 18, 2024
25 Aug 2022

Acarix AB (publ) publicerar delårsrapport, januari – juni 2022

Stort intresse och positiv utveckling på den amerikanska marknadenVi kan nu konstatera att vår Go-To-Market strategi i USA ...
Continue reading
author-avatar acarix
Corporate Information, IR, Listing Regulation, News, Other Corporate Information, Regulatory, Swedish
November 18, 2024
22 Jun 2022

Acarix tecknar samarbetsavtal med Strategic Health AK för att införa CADScor®System i Alaska

Pressmeddelande Malmö, 22 juni, 2022  Acarix tecknar samarbetsavtal med Strategic Health AK för att inför...
Continue reading
author-avatar acarix
Corporate Information, English, IR, Listing Regulation, News, Other Corporate Information, Regulatory
November 18, 2024
22 Jun 2022

Acarix partners with Strategic Health AK to roll-out CADScor®System across the state of Alaska

Press release Malmö, Sweden, June 22, 2022   Acarix partners with Strategic Health AK to roll-out CADScor®Syst...
Continue reading
author-avatar acarix
Corporate Information, General meeting, IR, Listing Regulation, News, Regulatory, Report of the AGM, Swedish
November 18, 2024
11 May 2022

Kommuniké från årsstämman i Acarix

Pressmeddelande Malmö, 11 maj 2022   Kommuniké från årsstämman i Acarix Årsstä...
Continue reading
  • «
  • ‹
  • 5
  • 6
  • 7
  • 8
  • 9
  • ›
  • »
Acarix AB
Jungmansgatan 12
211 19 Malmö
SE
[email protected]

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V5

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.